Community pharmacist intervention to optimize statin adherence in diabetes care: The GuIDE-S study.
J Am Pharm Assoc (2003)
; 63(3): 946-951, 2023.
Article
en En
| MEDLINE
| ID: mdl-36933697
ABSTRACT
BACKGROUND:
Statin use in people with type 2 diabetes (T2D) reduces cardiovascular events, yet adherence remains suboptimal.OBJECTIVE:
This study evaluated the impact of a community pharmacist intervention on statin adherence in new users with T2D.METHODS:
As part of a quasi-experimental study, community pharmacy staff proactively identified adult patients with T2D who were not prescribed a statin. When appropriate, the pharmacist prescribed a statin via a collaborative practice agreement or facilitated acquisition of a prescription from another prescriber. Patients received individualized education and follow-up and monitoring for 1 year. Adherence was defined as the proportion of days covered (PDC) by a statin over 12 months. Linear and logistic regression were used to compare the effect of the intervention on continuous and a binary adherence threshold, defined as PDC ≥ 80%, respectively.RESULTS:
Overall, 185 patients started statin therapy and were matched to 370 control patients for analysis. Adjusted average PDC was 3.1% higher in the intervention group (95% CI -0.037 to 0.098). Patients in the intervention group were 21.2% more likely to have PDC ≥ 80% (95% CI 0.828-1.774).CONCLUSION:
The intervention resulted in higher statin adherence than usual care; however, the differences were not statistically significant.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Inhibidores de Hidroximetilglutaril-CoA Reductasas
/
Diabetes Mellitus Tipo 2
Tipo de estudio:
Observational_studies
Límite:
Adult
/
Humans
Idioma:
En
Revista:
J Am Pharm Assoc (2003)
Asunto de la revista:
FARMACIA
Año:
2023
Tipo del documento:
Article